Intermittent Preventive Treatment in Infants as a Means of Malaria Control: a Randomized, Double-Blind, Placebo-Controlled Trial in Northern Ghana

Intermittent Preventive Treatment in Infants as a Means of Malaria Control: a Randomized, Double-Blind, Placebo-Controlled Trial in Northern Ghana

Abstract

CONTENT ALERTS Receive: RSS Feeds, eTOCs, free email alerts (when new articles cite this article), more» Information about commercial reprint orders: http://aac.asm.org/site/misc/reprints.xhtml To subscribe to to another ASM Journal go to: http://journals.asm.org/site/subscriptions/ ERRATUM Frank P. Mockenhaupt, Klaus Reither, Philipp Zanger, Felix Roepcke, Ina Danquah, Eiman Saad, Peter Ziniel, Stephen Y. Dzisi, Marc Frempong, Patrick Agana-Nsiire, Felicia Amoo-Sakyi, Rowland Otchwemah, Jakob P. Cramer, Sylvester D. Anemana, Ekkehart Dietz, and Ulrich Bienzle Downloaded from http://aac.asm.org/ on January 23, 2012 by deepdyve Institute of Tropical Medicine and International Health, Charité—University Medicine Berlin, Berlin, Germany; Northern Region Malaria Project (NORMAP), Tamale, Ghana; Regional Health Administration, Bolgatanga, Ghana; School of Medicine and Health Sciences, University for Development Studies, Tamale, Ghana; Regional Health Administration, Takoradi, Ghana; and Institute of Biostatistics and Clinical Epidemiology, Charité—University Medicine Berlin, Berlin, Germany Volume 51, no. 9, p. 3273–3281, 2007. Page 3274, column 1, line 17 from bottom: “125/6.25 mg of sulfadoxine and pyrimethamine, respectively, per kg of body weight” should read “250 and 12.5 mg of sulfadoxine and pyrimethamine, respectively.” Copyright © 2012, American Society for Microbiology. All Rights Reserved. doi:10.1128/AAC.06044-11 aac.asm.org 0066-4804/12/$12.00 Antimicrobial Agents and Chemotherapy p. 600